Abstract
John M. Eagles suggested that polioviruses might cause schizophrenia because 1) several reports of a recent decline in the incidence of schizophrenia coinciding with the introduction of polio vaccination, 2) the observed winter excesses in schizophrenic births (in temperate climates) could be explained by fetal exposure to poliovirus during the second trimester of gestation which would occur during the summer when polio epidemics are most frequent, 3) there are increased rates of schizophrenia among immigrants to the UK from regions of the world with low frequencies if immunity to polioviruses, 4) there may be genetic variants in the poliovirus receptor gene that could increase susceptibility to poliovirus infection (1). The large discordance rates for schizophrenia in monozygotic twin pairs indicate the existence of both genetic and environmental factors. Numerous genetic studies indicate an interaction of several genes in the etiology of schizophrenia. These genes may encode a family of poliovirus receptor subunits, various active combinations of which are expressed on T-immunocytes, monocytes, endothelial cells, and limited populations of (glutamatergic?) neurons. The poliovirus receptor on the T-cell may require both a specific combination of V segments of the T-cell antigen receptor, as well as a specific major histocompatibility (MHC) antigen, acting in concert to infect monocytes, the primary transporter of poliovirus from blood into the brain. The very large discordance rates for schizophrenia that probably exist for dichorionic-monozygotic twins (about 90%), as well as the much smaller discordance rates for monochorionic-monozygotic twins (about 40%), may be due to several allelic exclusion events expressed both in T-cells and possibly in certain neurons. A child who has lost some glutamatergic neurons due to viral infection during the second trimester of gestation, may be able to compensate for this deficit to a large extent by the super-abundance of excitatory synapses that exists in the brain until sexual maturity, at which time a selective loss of excitatory (mainly glutamatergic) synapses occurs together with hormonally induced changes in behavior, leading to a much increased risk of a psychotic episode.
Article PDF
REFERENCES
Eagles, J. M. 1992. Are polioviruses a cause of schizophrenia? Br. J. Psychiat. 160:598–600.
Squires, R. F., and Saederup, E. 1991. A review of evidence for GABergic predominance/glutamatergic deficit as a common etiological factor in both schizophrenia and affective psychoses: more support for a continuum hypothesis of “functional” psychoses. Neurochem. Res. 16:1099–1111.
Squires, R. F., and Saederup, E. 1997. Clozapine and some other antipsychotic drugs may preferentially block the same subset of GABAA receptors. Neurochem. Res. 22:151–162.
Squires, R. F. 1992. Are polioviruses a cause of schizophrenia? Br. J. Psychiat. 161:427 (Letter to Editor).
Squires, R. F., Lajtha, A., Saederup, E., and Palkovits, M. 1993. Reduced [3H]flunitrazepam binding in cingulate cortex and hippocampus of postmortem schizophrenic brains: is selective loss of glutamatergic neurons associated with major psychoses? Neurochem. Res. 18:219–223.
Torrey, E. F. 1988. Stalking the schizovirus. Schizophrenia Bull. 14:223–229.
Torrey, E. F. 1991. A viral-anatomical explanation of schizophrenia. Schizophrenia Bull. 17:15–18.
Kaufmann, C. A., Weinberger, D. R., Stevens, J. R., Asher, D. M., Kleinman, J. E., Sulima, M. P., Gibbs, C. J., Jr., and Gajdusek, C. 1988. Intracerebral inoculation of experimental animals with brain tissue from patients with schizophrenia. Arch. Gen. Psychiat. 45:648–652.
Taller, A. M., Asher, D. M., Pomeroy, K. L., Eldadah, B. A., Godec, M. S., Falkai, P. G., Bogert, B., Kleinman, J. E., Stevens, J. R., and Torrey, E. F. 1996. Search for viral nucleic acid sequences in brain tissues of patients with schizophrenia using nested polymerase chain reaction. Arch. Gen. Psychiat. 53:32–40.
Torrey, E. F., Rawlings, R., and Waldman, I. N. 1988. Schizophrenia births and viral diseases in two states. Schizo. Res. 1:73–77.
Bodian, D. 1947. Poliomyelitis. Neuropathologic observations in relation to motor symptoms. J. Amer. Med. Assoc. 134:1149–1154.
Johnson, R. T. 1985. Acute anterior poliomyelitis. In: Wyngaarden, J. B., Smith, L. H. Jr. (Eds), Cecil Textbook of Medicine. W. B. Saunders, 2130–2132.
Ren, R., and Racaniello, V. R. 1992. Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice. J. Virol. 66:296–304.
Brown, R. H., Jr., Johnson, D., Ogonowski, M., and Weiner, H. L. 1987. Type I human poliovirus binds to human synaptosomes. Ann. Neurol. 21:64–70.
Pritchett, D. B., Sontheimer, H., Shivers, B. D., Ymer, S., Kettenmann, H., Schofield, P. R., and Seeburg, P. H. 1989. Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology. Nature 338:582–585.
Pritchett, D. B., Lüddens, H., and Seeburg, P. H. 1989. Type I and Type II GABAA benzodiazepine receptors produced in transfected cells. Science 245:1389–1392.
Deng, H., Liu, R., Ellmeir, W., Choe, S., Unutmaz, D., Burkhart, M., Di Marzio, P., Marmon, S., Sutton, R. E., Hill, C. M., Davis, C. B., Peiper, S. C., Schall, T. J., Littman, D. R., and Landau, N. R. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661–666.
Dragic, T., Litwin, V., Allaway, G. P., Martin, S. R., Huang, Y., Nagashima, K. A., Cayanan, C., Maddon, P. J., Koup, R. A., Moore, J. P., and Paxton, W. A. 1996. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667–673.
Morris, P. J. and Pietsch, M. C. 1973. A possible association between paralytic poliomyelitis and multiple sclerosis. Lancet II:847.
Pietsch, M. C., and Morris, P. J. 1974. An association of HL-A3 and HL-A7 with paralytic poliomyelitis. Tissue Antigen 4:50–55.
Steigman, A. J. 1973. HL-A types and paralytic poliomyelitis. Lancet II:1383.
Torrey, E. F., Bowler, A. E., Taylor, E. H., and Gottesman, I.I. 1994. Schizophrenia and Manic-Depressive Disorder, Basic Books, New York, N.Y.
Gregersen, P. K. 1993. Discordance for autoimmunity in monozygotic twins. Are “identical” twins really identical? Arthritis Rheum. 36:1185–1192.
Ivanyi, P., Droes, J., Schreuder, G. M. Th., D'Amaro, J., and van Rood, J. J. 1983. A search for association of HLA antigens with paranoid schizophrenia. Tissue Antigen 22:186–193.
Miyanaga, K., Machiyama, Y., and Juji, T. 1984. Schizophrenic disorders and HLA-DR antigens. Biol. Psychiat. 19:121–129.
Cazzullo, C. L., Smeraldi, E., and Penati, G. 1974. The leukocyte antigenic system HL-A as a possible genetic marker of schizophrenia. Brit. J. Psychiat. 125:25–27.
Gattaz, W. F., Beckmann, H., and Mendlewicz, J. 1981. HLA antigens and schizophrenia: a pool of two studies. Psychiat. Res. 5:123–128.
McGuffin, P., Farmer, A. E., and Yonace, A. H. 1981. HLA antigens and subtypes of schizophrenia. Psychiat. Res. 5:115–122.
Crowe, R. R., Thompson, J. S., Flink, R., and Weinberger, B. 1979. HLA antigens and schizophrenia. Arch. Gen. Psychiat. 36:231–233.
Özcan, M. E., Taskin, R., Banoglu, R., Babacan, M., and Tuncer, E. 1996. HLA antigens in schizophrenia and mood disorders. Biol. Psychiat. 39:891–895.
Nimgaonkar, V. L., Rudert, W. A., Zhang, X. R., Tsoi, W-F., Trucco, M., and Saha, N. 1995. Further evidence for an association between schizophrenia and the HLA DQB1 gene locus. Schizophr. Res. 18:43–49.
Eaton, W. W., Hayward, C., and Ram, R. 1992. Schizophrenia and rheumatoid arthritis: a review. Schizophr. Res. 6:181–192.
Feldmann, M., Brennan, F. M., and Maini, R. N. 1996. Rheumatoid arthritis. Cell 85:307–310.
Wright, P., Sham, P. C., Gilvarry, C. M., Jones, P. B., Cannon, M., Sharma, T., and Murray, R. M. 1996. Autoimmune diseases in the pedigrees of schizophrenic and control subjects. Schizophr. Res. 20:261–267.
Wright, P., Donaldson, P. T., Underhill, J. A., Choudhuri, K., Doherty, D. G., and Murray, R. M. 1996. Genetic association of the HLA DRB1 gene locus on chromosome 6p21.3 with schizophrenia. Amer. J. Psychit. 153:1530–1533.
Straub, R. E., MacLean, C. J., O'Neill, F. A., Burke, J., Murphy, B., Duke, F., Shinkwin, R., Webb, B. T., Zhang, J., Walsh, D., and Kendler, K. S. 1995. A potential vulnerability locus for schizophrenia on chromosome 6p24–22 evidence for genetic heterogeneity. Nat. Genet. 11:287–293.
Schwab, S. G., Albus, M., Hallmayer, J., Hönig, S., Borrmann, M., Lichtermann, D., Ebstein, R. P., Ackenheil, M., Lerer, B., Risch, N., Maier, W., and Wildenauer, D. B. 1995. Evaluation of a susceptibility gene for schizophrenia on chromosome 6p by multipoint affected sib-pair linkage analysis. Nat. Genet. 11:325–327.
Moises, H. W., Yang, L., Kristbjarnarson, H., Wiese, C., Byerley, W., Macciardi, F., Arolt, V., Blackwood, D., Liu, X., Sjögren, B., Aschauer, H. N., Hwu, H.-G., Jang, K., Livesley, W. J., Kennedy, J. L., Zoega, T., Ivarsson, O., Bui, M.-T., Yu, M.-H., Havsteen, B., Commenges, D., Weissenbach, J., Schwinger, E., Gottesman, I. I., Pakstis, A. J., Wetterberg, L., Kidd, K. K., and Helgason, T. 1995. An international two-stage genome-wide search for schizophrenia susceptibility genes. Nat. Genet. 11:321–324.
Alexander, R. C., Coggiano, M., Daniel, D. C., and Wyatt, R. J. 1990. HLA antigens in schizophrenia. Psychiat. Res. 31:221–233.
Campion, D., Leboyer, M., Hillaire, D., Halle, L., Gorwood, P., Cavelier, B., Soufflet, M. F., D'Amato, T., Muller, B., Kaplan, C., Jay, M., and Clerget-Darpoux, F. 1992. Relationship of HLA to schizophrenia not supported in multiplex families. Psychiat. Res. 41:99–105.
Wekerle, H., Linington, C., Lassmann, H., and Meyermann, R. 1986. Cellular immune reactivity within the CNS. TINS 9:271–277.
Luber-Narod, J., and Rogers, J. 1988. Immune system associated antigens expressed by cells of the human central nervous system. Neurosci. Lett. 94:17–22.
Aldrich, M. S. 1992. Narcolepsy. Neurology 42:34–43.
Douglass, A. B., Harris, L., and Pazderka, F. 1989. Monozygotic twins concordant for the narcoleptic syndrome. Neurology 39:140–141.
Montplaisir, J., and Poirier, G. 1987. Narcolepsy in monozygotic twins. Neurology 37:1089.
Billiard, M., and Seignalet, J. 1985. Extraordinary association between HLA-DR2 and narcolepsy. Lancet I:226–227.
Marcadet, A., Gebuhrer, L., Betuel, H., Seignalet, J., Freidel, A. C., Confavreux, C., Billiard, M., Dausett, J., and Cohen, D. 1985. DNA polymorphism related to HLA-DR2 Dw2 in patients with narcolepsy. Immunogenetics 22:679–683.
Douglass, A. B., Hays, P., Pazderka, F., and Russell, J. M. 1991. Florid refractory schizophrenias that turn out to be treatable variants of HLA-associated narcolepsy. J. Nerv. Ment. Dis. 179:12–17.
Roy, A. 1976. Psychiatric aspects of narcolepsy. Brit. J. Psychiat. 128:562–565.
Franco, B., Guioli, S., Pragliola, A., Incerti, B., Bardoni, B., Tonlorenzi, R., Carrozzo, R., Maestrini, E., Pieretti, M., Taillon-Miller, P., Brown, C. J., Willard, H. F., Lawrence, C., Persico, M. G., Camerino, G., and Ballabio, A. 1991. A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules. Nature 353:529–536.
Legouis, R., Hardelin, J.-P., Levilliers, J., Claverie, J.-M., Compain, S., Wunderle, V., Millasseau, P., Le Paslier, D., Cohen, D., Caterina, D., Bougueleret L., Delemarre-Van de Waal, H., Lutfalla, G., Weissenbach, J., and Petit, C. 1991. The candidate gene for the x-linked Kallmann syndrome encodes a protein related to adhesion molecules. Cell 67:423–435.
Cowen, M. A., and Green, M. 1993. The Kallmann's syndrome variant (KSV) model of the schizophrenias. Schizo. Res. 9:1–10.
Crow, T. J. 1993. Sexual selection, Machiavellian intelligence, and the origins of psychosis. Lancet 342:594–598.
Benes, F. M., Davidson, J., and Bird, E. D. 1986. Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. Arch. Gen. Psychiat. 43:31–35.
Meltzer, H. Y., and Crayton, J. W. 1974. Subterminal motor nerve abnormalities in psychotic patients. Nature 249:373–375.
Crayton, J. W., and Meltzer, H. Y. 1979. Degeneration and regeneration of motor neurons in psychotic patients. Biol. Psychiat. 14:803–819.
Howland, R. H. 1990. Schizophrenia and amyotrophic lateral sclerosis. Compr. Psychiat. 31:327–336.
Karson, C. N., Casanova, M. F., Kleinman, J. E., and Griffin, W. S. T. 1993. Choline acetyltransferase in schizophrenia. Amer. J. Psychiat. 150:454–459.
Mednick, S. A., Machon, R. A., Huttunen, M. O., and Bonett, D. 1988. Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch. Gen. Psychiat. 45:189–192.
Barr, C. E., Mednick, S. A., and Munk-Jorgensen, P. 1990. Exposure to influenza epidemics during gestation and adult schizophrenia. Arch. Gen. Psychiat. 47:869–874.
O'Callaghan, E., Sham, P., Takei, N., Glover, G., and Murray, R. M. 1991. Schizophrenia after prenatal exposure to 1957 A2 influenza epidemic. Lancet 337:1248–1250.
Sham, P. C., O'Callaghan, E., Takei, N., Murray, G. K., Hare, E. H., and Murray, R. M. 1992. Schizophrenia following prenatal exposure to influenza epidemics between 1939 and 1960. Brit. J. Psychiat. 160:461–466.
Kendell, R. E., and Kemp, I. W. 1989. Maternal influenza in the etiology of schizophrenia. Arch. Gen. Psychiat. 46:878–882.
Crow, T. J., and Done, D. J. 1992. Prenatal exposure to influenza does not cause schizophrenia. Brit. J. Psychiat. 161:390–393.
Crow, T. J. 1994. Prenatal exposure to influenza as a cause of schizophrenia. Brit. J. Psychiat. 164:588–592.
Selten, J.-P. C. J., and Slaets, J. P. J. 1994. Evidence against maternal influenza as a risk factor for schizophrenia. Brit. J. Psychiat. 164:674–676.
Susser, E., Lin, S. P., Brown, A. S., Lumey, L. H., and Erlenmeyer-Kimling, L. 1994. No relation between risk of schizophrenia and prenatal exposure to influenza in Holland. Amer. J. Psychiat. 151:922–924.
Douglas, R. G., Jr. 1985. Influenza. In: J. B. Wyngaarden, J. B. Smith, L. H., Jr. (Eds). Cecil Textbook of Medicine. W. B. Saunders, pp. 1700–1705.
Menninger, K. A. 1926. Influenza and schizophrenia. Amer. J. Psychiat. V:469–529.
Paul, J. R. 1971. A History of Poliomyelitis, Yale University Press, New Haven and London.
Parish, J. G. 1978. Early outbreaks of ‘epidemic neuromyasthenia.’ Postgrad. Med. J. 54:711–717.
Gow, J. W., Behan, W. M. H., Clements, G. B., Woodall, C., Riding, M., and Behan, P. O. 1991. Enteroviral RNA sequences detected by polymerase chain reaction in muscle of patients with postviral fatigue syndrome. BMJ 302:692–696.
Davis, J. O., and Phelps, J. A. 1995. Twins with schizophrenia: genes or germs? Schizophrenia Bull. 21:13–18.
Davis, J. O., Phelps, A., and Bracha, H. S. 1995. Prenatal development of monozygotic twins and concordance for schizophrenia. Schizophrenia Bull. 21:357–366.
Zhang, L., van Rood, J. J., and Claas, F. H. J. 1991. The T-cell repertoire is not dictated by self antigens alone. Res. Immunol. 142:441–445.
Birnbaum, G., Kotilinek, L., Schwartz, M., and Sternad, M. 1986. Disparate responses of lymphocyte clones to cells of monozygotic twins discordant for multiple sclerosis. J. Neuroimmunol. 11:237–243.
Utz, U., Biddlson, W. E., McFarland, H. F., McFarlin, D. E., Flerlage, M., and Martin, R. 1993. Skewed T-cell receptor repertoire in genetically identical twins correlates with multiple sclerosis. Nature 364:243–247.
Oettinger, M. A., Schatz, D. G., Gorka, C., and Baltimore, D. 1990. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science 248:1517–1523.
Chun, M. J. M., Schatz, D. G., Oettinger, M. A., Jaenisch, R., and Baltimore, D. 1991. The recombination activating gene-1 (RAG-1) transcript is present in the murine central nervous system. Cell 64:189–200.
Matsuoka, M., Nagawa, F., Okazaki, K., Kingsbury, L., Yoshida, K., Müller, U., Larue, D. T., Winer, J. A., and Sakano, H. 1991. Detection of somatic DNA recombination in the transgenic mouse brain. Science 254:81–86.
Singer-Sam, J. 1991. An epigenetic role in schizophrenia. Schizophrenia Bull. 17:365.
Huttenlocher, P. R. 1979. Synaptic density in human frontal cortex — developmental changes and effects of aging. Brain Res. 163:195–205.
Zecevic, N., Bourgeois, J.-P., and Rakic, P. 1989. Changes in synaptic density in motor cortex of rhesus monkey during fetal and postnatal life. Develop. Brain Res. 50:11–32.
Bourgeois, J.-P., and Rakic, P. 1993. Changes of synaptic density in the primary visual cortex of the macaque monkey from fetal to adult stage. J. Neurosci. 13:2801–2820.
Feinberg, I. 1982–83. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J. Psychiat. Res. 17:319–334.
Keshavan, M. S., Anderson, S., and Pettegrew, J. W. 1994. Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. J. Psychiat. Res. 28:239–265.
Weinberger, D. R. 1987. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiat. 44:660–669.
Fañanas, L., van Os, J., Hoyos, C., McGrath, J., Mellor, C. S., and Murray, R. 1996. Dermatoglyphic a-b ridge count as a possible marker for developmental disturbance in schizophrenia: replication in two samples. Schizophr. Res. 20:307–314.
Davis, J. O., and Bracha, H. S. 1996. Prenatal growth markers in schizophrenia. A monozygotic co-twin control study. Amer. J. Psychiat. 153:1166–1172.
Eberle, K. E., Nguyen, V. T., and Freistadt, M. S. 1995. Low levels of poliovirus replication in primary human monocytes: possible interactions with lymphocytes. Arch. Virol. 140:2135–2150.
Freistadt, M. S., and Eberle, K. E. 1996. Correlation between poliovirus type 1 mahoney replication in blood cells and neurovirulence. J. Virol. 70:6486–6492.
Blinzinger, K., Simon, J., Magrath, D., and Boulger, L. 1969. Poliovirus crystals within the endoplasmic reticulum of endothelial and mononuclear cells in the monkey spinal cord. Science 163:1336–1337.
Kowall, N. W., and Beal, M. F. 1991. Glutamate-, glutaminase-, and taurine-immunoreactive neurons develop neurofibrillary tangles in Alzheimer's disease. Ann. Neurol. 29:162–167.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Squires, R.F. How a Poliovirus Might Cause Schizophrenia: A Commentary on Eagles' Hypothesis. Neurochem Res 22, 647–656 (1997). https://doi.org/10.1023/A:1022486423238
Issue Date:
DOI: https://doi.org/10.1023/A:1022486423238